New York · 2025 Regular Session · Bill

A 1720: Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy

In committee Last action January 7, 2026: REFERRED TO INSURANCE

Plain-language summary

A 1720 is a bill introduced in the New York House on January 14, 2025. According to its official title, it concerns: Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy. Primary sponsor: Linda Rosenthal (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO INSURANCE.

Sponsors

Primary sponsor: Linda Rosenthal (Democratic).